Scynexis (SCYX) EBT Margin (QoQ) (2013 - 2025)
Scynexis (SCYX) EBT Margin (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 263,790.00 |
| Sep 30, 2025 | -206,739.00 |
| Jun 30, 2025 | 159,290.00 |
| Mar 31, 2025 | -164,628.00 |
| Dec 31, 2024 | 3,392.00 |
| Sep 30, 2024 | 147,910.00 |
| Jun 30, 2024 | -203,301.00 |
| Mar 31, 2024 | 40,373.00 |
| Dec 31, 2023 | -23,535.00 |
| Sep 30, 2023 | -19,278.00 |
| Jun 30, 2023 | 309,088.00 |
| Mar 31, 2023 | -205,168.00 |
| Dec 31, 2022 | 95,387.00 |
| Sep 30, 2022 | -89,137.00 |
| Jun 30, 2022 | 44,145.00 |
| Mar 31, 2022 | 345,589.00 |
| Dec 31, 2021 | -477,909.00 |
| Jun 30, 2019 | 428,914.00 |
| Mar 31, 2019 | -502,812.00 |
| Dec 31, 2018 | 312,344.00 |